Keyphrases
Huntington's Disease
100%
Parkinson's Disease
80%
Early Parkinson's Disease
23%
Movement Disorders
23%
Complementary and
15%
Health-related Quality of Life
13%
Phase II Study
13%
Quality of Life
13%
DAT-SPECT Imaging
12%
Clinical Evidence
12%
Suicidal Behavior
12%
Tardive Dyskinesia
12%
Chorea
11%
Deutetrabenazine
11%
Wilson Disease
11%
Progressive Supranuclear Palsy
11%
Randomized Placebo-controlled Trial
11%
Age of Onset
11%
Complementary Medicine
10%
Cannabis
9%
DAT-SPECT
9%
Parkinson
8%
Neurology Residency
8%
Clinical Management
8%
Suicidal Ideation
8%
Mind-body Interventions
8%
Neutraceutical
7%
Placebo
7%
Psychosis
7%
Randomized Controlled Trial
7%
Clinical Characteristics
7%
Valproic Acid
7%
Depressive Symptoms
7%
Total Functional Capacity
7%
Incontinence
7%
Clinical Features
7%
Drug-induced Parkinsonism
7%
Neurology
7%
Young Males
6%
Dance Therapy
6%
Clinical Trials
6%
Unified Parkinson's Disease Rating Scale (UPDRS)
6%
Suicidal Thoughts
6%
Cannabis Use
6%
Exploratory Trial
6%
Acupuncture
6%
NINDS
6%
Monoclonal Antibody
6%
Beck Depression inventory-II (BDI-II)
6%
Family History
6%
Medicine and Dentistry
Parkinson's Disease
52%
Huntington's Disease
49%
Stereotypic Movement Disorder
23%
Neurology
20%
Diseases
19%
Placebo
12%
Progressive Supranuclear Palsy
11%
Chorea
11%
Medicine
11%
Parkinsonism
11%
Quality of Life
10%
Functional Status
7%
Single-Photon Emission Computed Tomography
7%
Mind-Body Interventions
7%
Family History
7%
Acupuncture
7%
Clinical Feature
7%
Complementary and Alternative Medicine
6%
Incontinence
6%
Cannabis
6%
Monoclonal Antibody
6%
Temporal Lobe
5%
Meta-Analysis
5%
Health Care
5%
Spasmodic torticollis
5%
Peripheral Nervous System
5%
Metastatic Carcinoma
5%
Wilson's Disease
5%
Systematic Review
5%
Primary Health Care
5%
Prasinezumab
5%
Clear Cell Renal Cell Carcinoma
5%
Status Epilepticus
5%
Beck Depression Inventory
5%
Ioflupane I 123
5%
Leukoencephalopathy
5%
Diamorphine
5%
Leg
5%
Diffusion MRI
5%
Adjuvant Therapy
5%
Weakness
5%
Electroconvulsive Therapy
5%
Attitude
5%
Clinical Management
5%
Gosuranemab
5%
Restless Legs Syndrome
5%
Medical Cannabis
5%
Caregiver Burden
5%
Valbenazine
5%
Sodium Valproate
5%